• Issue

    Hematological Oncology: Volume 41, Issue 4

    603-791
    October 2023
Previous Issue|Next Issue
Export Citation(s)Download PDF(s)

ISSUE INFORMATION

Free Access

Issue Information

  • Pages: 603-604
  • First Published: 08 October 2023

EDITORIAL

Open Access

Reducing the risks of nuclear war—The role of health professionals

Kamran Abbasi,  Parveen Ali,  Virginia Barbour,  Kirsten Bibbins-Domingo,  Marcel G. M. Olde Rikkert,  Richard Horton,  Robert Mash,  Carlos Monteiro,  Elena N. Naumova,  Eric J. Rubin,  Peush Sahni,  James Tumwine,  Paul Yonga,  Chris Zielinski,  Arun Mitra,  Tilman Ruff,  Andy Haines,  Ira Helfand, 
  • Pages: 605-607
  • First Published: 14 September 2023

PERSPECTIVE

Open Access

Revisiting the predictive role of 18F-fluorodeoxyglucose positron emission tomography/computerized tomography on treatment outcome in early-stage favorable Hodgkin lymphoma

Andrea Gallamini,  Axel Sudria,  Michał Kurlapski,  Lauris Gastaud, 
  • Pages: 608-611
  • First Published: 20 April 2023

REVIEWS

Myelodysplastic syndromes with ring sideroblasts

Antonella Bruzzese,  Ernesto Vigna,  Enrica Antonia Martino,  Francesco Mendicino,  Eugenio Lucia,  Virginia Olivito,  Carlo Bova,  Angelo Barbato,  Gianfranco Filippelli,  Isabella Capodanno,  Antonino Neri,  Fortunato Morabito,  Massimo Gentile, 
  • Pages: 612-620
  • First Published: 16 February 2023
Open Access

Real-world evidence on venetoclax in chronic lymphocytic leukemia: The Italian experience

Luca Laurenti,  Lydia Scarfò,  Anna Maria Frustaci,  Alessandro Sanna,  Emilia Iannella,  Morena Caira,  Paola Finsinger,  Silvia Schifano,  Benedetta Neri,  Stefano Molica,  Francesca Romana Mauro, 
  • Pages: 621-630
  • First Published: 20 January 2023

ORIGINAL ARTICLES

Open Access

Genomic landscape of follicular lymphoma across a wide spectrum of clinical behaviors

Pablo Mozas,  Cristina López,  Marta Grau,  Ferran Nadeu,  Guillem Clot,  Sara Valle,  Marta Kulis,  Alba Navarro,  Joan Enric Ramis-Zaldivar,  Blanca González-Farré,  Alfredo Rivas-Delgado,  Andrea Rivero,  Gerard Frigola,  Olga Balagué,  Eva Giné,  Julio Delgado,  Neus Villamor,  Estella Matutes,  Laura Magnano,  Ramón García-Sanz,  Sarah Huet,  Robert B. Russell,  Elías Campo,  Armando López-Guillermo,  Sílvia Beà, 
  • Pages: 631-643
  • First Published: 30 March 2023
Open Access

Molecular classification and identification of an aggressive signature in low-grade B-cell lymphomas

Melissa A. Hopper,  Kerstin Wenzl,  Keenan T. Hartert,  Jordan E. Krull,  Abigail R. Dropik,  Joseph P. Novak,  Michelle K. Manske,  MaKayla R. Serres,  Vivekananda Sarangi,  Melissa C. Larson,  Matthew J. Maurer,  Zhi-Zhang Yang,  Jonas Paludo,  Ellen D. McPhail,  Thomas M. Habermann,  Brian K. Link,  Lisa M. Rimsza,  Stephen M. Ansell,  James R. Cerhan,  Dragan Jevremovic,  Anne J. Novak, 
  • Pages: 644-654
  • First Published: 30 May 2023
Open Access

Impact of immunochemotherapy with R-bendamustine or R-CHOP for treatment naïve advanced-stage follicular lymphoma: A subset analysis of the FOLL12 trial by Fondazione Italiana Linfomi

Maria E. Nizzoli,  Martina Manni,  Chiara Ghiggi,  Alessandro Pulsoni,  Gerardo Musuraca,  Michele Merli,  Catello Califano,  Alessia Bari,  Massimo Massaia,  Annarita Conconi,  Pellegrino Musto,  Donato Mannina,  Tommasina Perrone,  Francesca Re,  Sara Galimberti,  Guido Gini,  Monia Capponi,  Umberto Vitolo,  Sara V. Usai,  Piero M. Stefani,  Filippo Ballerini,  Anna M. Liberati,  Elsa Pennese,  Domenico Pastore,  Tetiana Skrypets,  Hillary Catellani,  Luigi Marcheselli,  Massimo Federico,  Stefano Luminari, 
  • Pages: 655-662
  • First Published: 28 May 2023
Open Access

Glofitamab in relapsed/refractory diffuse large B-cell lymphoma: Real-world data

Elif Birtas Atesoglu,  Zafer Gulbas,  Ant Uzay,  Muhit Ozcan,  Fahir Ozkalemkas,  Mehmet Sinan Dal,  Hakan Kalyon,  Olga Meltem Akay,  Burak Deveci,  Huseyin Bekoz,  Omur Gokmen Sevindik,  Tayfur Toptas,  Fergun Yilmaz,  Derya Koyun,  Nihan Alkis,  Inci Alacacioglu,  Mehmet Sonmez,  Irfan Yavasoglu,  Anil Tombak,  Ozgur Mehtap,  Fatih Kurnaz,  Orhan Kemal Yuce,  Volkan Karakus,  Mehmet Turgut,  Derya Deniz Kurekci,  Mesut Ayer,  Muzaffer Keklik,  Deram Buyuktas,  Murat Ozbalak,  Burhan Ferhanoglu, 
  • Pages: 663-673
  • First Published: 22 May 2023
Open Access

[18F]-FDG PET radiomic model as prognostic biomarker in diffuse large B-cell lymphoma

Laura Lavinia Travaini,  Francesca Botta,  Enrico Derenzini,  Giuliana Lo Presti,  Mahila Esmeralda Ferrari,  Lighea Simona Airò Farulla,  Tommaso Radice,  Saveria Mazzara,  Corrado Tarella,  Stefano Pileri,  Sara Raimondi,  Francesco Ceci, 
  • Pages: 674-682
  • First Published: 20 May 2023

Significant reduction in the incidence of non-coronavirus infections in patients with chronic lymphocytic leukemia on ibrutinib and venetoclax treatment during the COVID-19 pandemic: An additional benefit of lockdown

Maria Kislova,  Andrei Petrenko,  Elena A. Dmitrieva,  Alexander Milenkin,  Konstantin E. Nikitin,  Vadim V. Ptushkin,  Alexey V. Shabunin,  Eugene A. Nikitin, 
  • Pages: 683-693
  • First Published: 14 April 2023

LncRNA FEZF1-AS1 accelerates multiple myeloma progression by regulating IGF2BP1/BZW2 signaling

Xingxing Long,  Feng Wen,  Junjun Li,  Xiaoqing Huang, 
  • Pages: 694-703
  • First Published: 01 May 2023

A comprehensive analysis of coagulopathy during anti-B cell maturation antigen chimeric antigen receptor-T therapy in multiple myeloma, a retrospective study based on LEGEND-2

Rui Liu,  Yang Lv,  Fei Hong,  Wanhong Zhao,  Bo Lei,  Jie Liu,  Wanggang Zhang,  Aili He,  Fangxia Wang, 
  • Pages: 704-717
  • First Published: 25 April 2023

Intravenous immunoglobulin prophylaxis is associated with decreased rate of infection-related hospitalizations in multiple myeloma patients

Michael Sheu,  Sofia Molina Garcia,  Meera Patel,  Lauren Granat,  Louis Williams,  Jack Khouri,  Sherif Mossad,  Faiz Anwer,  Aneela Majeed, 
  • Pages: 718-724
  • First Published: 25 May 2023

Outcomes for patients with systemic light chain amyloidosis and Mayo stage 3B disease

Foteini Theodorakakou,  Alexandros Briasoulis,  Despina Fotiou,  Ioannis Petropoulos,  Georgios Georgiopoulos,  Niki Lama,  Nikolaos Kelekis,  Evangelos Repasos,  Magdalini Migkou,  Kimon Stamatelopoulos,  Meletios A Dimopoulos,  Efstathios Kastritis, 
  • Pages: 725-732
  • First Published: 27 March 2023

The effect of haploidentical hematopoietic stem cell transplantation on comutations based on next-generation sequencing in adult acute myeloid leukemia patients with the FLT3-ITD mutation

Feifei Tang,  Xiaosu Zhao,  Guorui Ruan,  Qian Jiang,  Hao Jiang,  Lanping Xu,  Yu Wang,  Xiaohui Zhang,  Kaiyan Liu,  Xiaojun Huang, 
  • Pages: 733-742
  • First Published: 04 June 2023
Open Access

A phase 1b study of venetoclax and alvocidib in patients with relapsed/refractory acute myeloid leukemia

Brian A. Jonas,  Jing-Zhou Hou,  Gail J. Roboz,  Caroline L. Alvares,  Deepa Jeyakumar,  John R. Edwards,  Harry P. Erba,  Richard J. Kelly,  Christoph Röllig,  Walter Fiedler,  Deanna Brackman,  Satya R. Siddani,  Brenda Chyla,  Jacqueline Hilger-Rolfe,  Justin M. Watts, 
  • Pages: 743-752
  • First Published: 22 April 2023

Patients with secondary acute myeloid leukemia undergoing allogeneic stem-cell transplant have inferior outcomes than de novo acute myeloid leukemia regardless minimal residual disease level by flow cytometry

Claudia Núñez-Torrón Stock,  Carlos Jiménez Chillón,  Fernando Martín Moro,  Juan Marquet Palomanes,  Kyra Velázquez Kennedy,  Miguel Piris Villaespesa,  Ernesto Roldán Santiago,  Eulalia Rodríguez Martín,  Anabelle Chinea Rodríguez,  Valentín García Gutiérrez,  Gemma Moreno Jiménez,  Javier López Jiménez,  Pilar Herrera Puente, 
  • Pages: 753-761
  • First Published: 20 April 2023

CASE REPORT

Increased neopterin in cerebrospinal fluid in active adult neurohistiocytosis

Jerome Razanamahery,  Maxime Samson,  Ahmed Idbaih,  Helene Greigert,  Pierre Olivier Comby,  Fleur Cohen Aubart,  Julien Haroche,  Sylvain Audia,  Bernard Bonnotte, 
  • Pages: 762-767
  • First Published: 11 June 2023

LETTERS TO THE EDITOR

Whole exome sequencing of primary cutaneous CD4+ small/medium T-cell lymphoproliferative disorders

Craig R. Soderquist,  Susan Hsiao,  Jiuhong Pang,  Alejandro A. Gru,  Sameera Husain,  Bachir Alobeid,  Govind Bhagat, 
  • Pages: 768-770
  • First Published: 03 April 2023

Refining prognosis in chronic lymphocytic leukemia with normal Fluorescence in situ hybridization results

Matthew R. Avenarius,  Ying Huang,  Jonathan Hyak,  John C. Byrd,  Seema A. Bhat,  Michael Grever,  Adam S. Kittai,  Kerry A. Rogers,  Dan Jones,  Weiqiang Zhao,  Nyla A. Heerema,  Lynne V. Abruzzo,  Jennifer Woyach,  Cecelia R. Miller, 
  • Pages: 771-775
  • First Published: 03 April 2023

Treatment intensification might not improve survival in high-grade B-cell lymphoma with a concurrent MYC and BCL2 and/or BCL6 rearrangement: A retrospective, multicenter, pooled analysis

Vanja Zeremski,  Ellen D. McPhail,  Thomas M. Habermann,  Francesca Schieppati,  Niklas Gebauer,  Theodoros P. Vassilakopoulos,  Dimitrios Mougiakakos, 
  • Pages: 776-780
  • First Published: 21 March 2023

Mortality in COVID-19 hospitalizations with underlying hematologic malignancies in the United States

Aditi Sharma,  Abhinav Deol,  Vijendra Singh, 
  • Pages: 781-783
  • First Published: 13 May 2023

Report of PRPF19 as a novel partner of RARG and the recurrence of interposition-type fusion in variant acute promyelocytic leukemia

Huanling Wu,  Hongjun Li,  Xiaosu Zhou,  Zongchen Zhao,  Panxiang Cao,  Li Li,  Xiaoli Ma,  Lili Yuan,  Fang Wang,  Yang Zhang,  Jiaqi Chen,  Jiancheng Fang,  Ming Liu,  Mingyue Liu,  Xue Chen,  Hongxing Liu, 
  • Pages: 784-788
  • First Published: 02 May 2023
Open Access

A five-gene signature may associate with central nervous system dissemination in adult acute lymphoblastic leukemia

Maria Rosaria Sapienza,  Sabina Chiaretti,  Deborah Cardinali,  Saveria Mazzara,  Roberto Chiarle,  Robin Foà,  Stefano A. Pileri, 
  • Pages: 789-791
  • First Published: 05 April 2023